The Global Healthcare ERP Market size is expected to reach $9,399. 8 million by 2027, rising at a market growth of 6. 5% CAGR during the forecast period. Healthcare facilities and firms are highly embracing cloud-based ERP systems because of the various advantages related to them, like minimum ownership cost, low availability of in-house technical expertise, agile and flexible infrastructure capacity, less capital requirement, and constant upgrades.
New York, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Healthcare ERP Market By Function, By Deployment, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027" - https://www.reportlinker.com/p06193312/?utm_source=GNW As on-premises systems need massive capital expenditure and a significant cost, small and medium companies are highly embracing cloud-based ERP systems. The rise in deployment of ERP systems among small and medium businesses is boosting demand for these systems to bring down operational costs and improve functional outcomes. Moreover, pharmacies and laboratories have started to embrace ERP systems for inventory management, accounts, purchase, point-of-sale profile, and selling. COVID-19 Impact Analysis The functioning of global healthcare systems has been severely challenged by the outbreak of the COVID-19 pandemic. The pandemic has put immense pressure on the workforce, highlighted limitations of current systems, and hampered the supply & demand cycles. With the drastic and rising transition towards remote healthcare and teleworking, companies are embracing cloud services to effortlessly access data, automate inventory and supply chain management functions, simplify the workflow, and enhance the financial & clinical outcomes of the industry. During the COVID-19 outbreak, numerous hospitals were willing to go live with their ERP. The adoption of ERP solutions has supported the supply chain of CentraCare’s, thereby placing the company in a better position to handle and manage the global pandemic. Market Growth Factors: Increasing need for Data Integration These systems enable companies to integrate data collected from human resources, supply chain cycles, manufacturing & inventories, and finances & accounting, and optimize back-end processes like payroll management, inventory management, and account management. Moreover, pharmacies and laboratories have started to embrace ERP systems for inventory management, accounts, purchase, point-of-sale profile, and selling. Rising awareness about the advantages of Healthcare ERP The rise in the installation rate of ERP systems among small and medium businesses is boosting demand for these systems to bring down operational costs and improve functional outcomes. Standardized patient data enables streamlined access from remote locations to enhance patient acquisition and patient management techniques. Healthcare facilities and firms are highly embracing cloud-based ERP systems because of the various advantages related to them, like minimum ownership cost, low availability of in-house technical expertise, agile and flexible infrastructure capacity, less capital requirement, and constant upgrades. Market Restraining Factor: Absence of well-skilled professionals The management of Healthcare ERP solutions needs many well-skilled employees and staff. On the other hand, the absence of proficient experts and staff has been a major obstacle barrier to the adoption of healthcare ERP solutions in the market. In addition, the healthcare ERP software and solutions must be regularly updated due to technological advancements. Additionally, data security is expected to become difficult as these systems collect data from various processes, computers, and networks that are highly susceptible to being hacked. Function Outlook Based on Function, the market is segmented into Finance and Billing, Supply Chain and Logistics Management, Inventory and Material Management, Patient Relationship Management, and Others. The finance and billing segment procured the maximum revenue share in 2020. Healthcare organizations are moving towards the deployment of ERP systems with an aim to optimize processes and reduce obstacles between front-end revenue cycle management activities and back-end activities, like claims management. Deployment Outlook Based on Deployment, the market is segmented into On-premises and Cloud. The on-premises deployment segment procured the maximum revenue share of the market of the overall healthcare ERP market in 2020. This is attributed to the various advantages like a low requirement for maintenance, less reliance on vendors, ease of access from any locations, reduced costs, full control over security & privacy, operations, and easy customization. Regional Outlook Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. In 2020, North America emerged as the leading region in the overall Healthcare ERP market. Factors such as quickly growing and robust healthcare infrastructure, the existence of major market players, and rising demand for sophisticated technological solutions are responsible for the growth of the regional market. The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix Microsoft Corporation is the major forerunners in the Healthcare ERP Market. Companies such as QAD, Inc., Aptean, Epicor Software Corporation are some of the key innovators in the Market. The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Microsoft Corporation, Oracle Corporation, SAP SE, McKesson Corporation, Sage Group Plc., Infor, Inc. (Koch Industries), Odoo, QAD, Inc. (Thoma Bravo), Aptean (Vista Equity Partners), and Epicor Software Corporation. Recent Strategies Deployed in Healthcare ERP Market Partnerships, Collaborations, and Agreements: Jul-2021: Infor entered into a partnership with Amazon Web Services (AWS), a subsidiary of Amazon providing on-demand cloud computing platforms and APIs. Through this partnership, the two entities would support the Health initiative from AWS to assist drive up operational efficiencies and generate insights, respond rapidly to unexpected circumstances, reduce costs, and enhance clinical and patient care. By harnessing the potential of AWS global infrastructure, Infor enables customers to realize advantages from AWS agility, cloud security, expertise, and economies of scale. Following the partnership, Infor would offer critical power and responsiveness to hospitals and health systems, so they can remain proactive in a growing complicated environment. May-2021: Oracle entered into a partnership with HealthPartners, an integrated health care organization providing health care services and health plan financing and administration. The partnership aimed to transfer HealthPartners’ business processes in finance, supply chain, and human resources to the cloud. Through this partnership, the Oracle Fusion Cloud Applications portfolio would overhaul and simplify work which is crucial for the success of HealthPartners. Mar-2021: Infor came into a partnership with C3 AI, a leading vendor of enterprise AI software. The partnership would broaden the enterprise-class artificial intelligence (AI) solutions across applicable industries to expand the native machine learning capabilities of Infor. Following the partnership, Infor would experience expansion in its product portfolio into edge scenarios and examine methods to offer better capabilities beyond its conventional offerings. Jan-2021: SAP expanded its partnership with Microsoft, an American multinational technology corporation. The expanded partnership would combine Microsoft Teams with an intelligent portfolio of solutions of SAP. In addition, the two companies aimed to expedite the adoption of SAP S/4HANA on Microsoft Azure. Following the partnership, the two entities would streamline and smooth out the journeys of customers to the cloud. Moreover, the two companies would enhance their ability to run a mission-critical intelligent enterprise on Azure while assisting customers to upgrade their enterprise applications. Nov-2020: Oracle partnered with Omega Healthcare, a premier vendor of RCM Solutions & Clinical Services for US Healthcare. Following the partnership, Omega aimed to gain a unified record of all the data (ERP, HCM, EPM, and CX) at the enterprise level, combining their current ecosystem of multiple applications. Through this partnership, Omega Healthcare would achieve a massive competitive edge from constant developments through quarterly updates. Moreover, the smooth data flow across business functions of human resources, finance, and sales would result in improved service delivery efficiency for Omega Healthcare with a superior customer experience. Aug-2020: QAD entered into a partnership with eNoah iSolutions, a popular company providing modern BPO and IT solutions worldwide. Following this partnership, eNoah iSolutions would become a reseller of QAD Adaptive ERP applications in North America. Jun-2020: Epico entered into a partnership with ETQ, a company that offers powerful compliance and quality management platform. Through this partnership, Epicor QMS further enhanced by ETQ Reliance. This cloud-based, agile quality system enables the clients to enhance quality processes to generate better financial results and get competitive advantages. May-2020: Epicor came into a partnership with Microsoft, an American multinational technology corporation. Through this partnership, Epicor would provide its enterprise-class solutions to the Azure platform of Microsoft. Moreover, the partnership would support the customer-centric focus of Epicor by Microsoft’s focus on the Intelligent Cloud and Intelligent Edge. May-2020: Oracle formed a partnership with KPMG, a British-Dutch multinational professional services network. Through this partnership, KPMG would allow clients to transfer their finance, supply chain functions and humna resources to the Oracle Cloud with the help of its Powered Healthcare which is a healthcare version of the company’s Powered Enterprise solution. Moreover, Oracehumand harness the experience and best practices of KPMG’s healthcare industry professionals to improve its cloud solutions for the healthcare industry. The Powered Healthcare of KPMG is built on a target operating model for business integrated with industry-leading practices of KPMG. Acquisitions and Mergers: Nov-2021: Aptean took over Objective Holding from Alpina Capital Partners and private shareholders. The acquisition would help Aptean to expand its supply chain offerings in Europe and add complementary solutions to Aptean’s ERP portfolio for process and discrete manufacturers. Following the partnership, Aptean would offer a wide range of solutions to its customers in the region. Oct-2021: Microsoft took over Clear Software, a company developing products to help automate repetitive business processes. The acquisition aimed to expand support for enterprise resource planning (ERP) integrations in Microsoft’s software package for automating routine business workflows. The product consists of over 100 present abstractions for business workflow development that work together with ERP systems like Oracle and SAP. The software is designed to copy a task being carried out manually on a computer. Jul-2021: Microsoft completed the acquisition of Suplari, a company that provides data analysis software for companies to manage supplier spending, and utilize the company’s capabilities to enhance its Dynamics 365 product. Following the acquisition, Microsoft aimed to integrate Suplari Spend Intelligence Cloud with Dynamics 365 and provides customers higher automation in terms of spending analysis and helping users to predict the better spend management actions. Jul-2021: Microsoft acquired Orions Systems, a company that offers digital video and data management solutions for organizations in the health care industry. Through this acquisition, Microsoft aimed to improve the video AI and management abilities of its Dynamics 365 Connected Store, an in-store retail optimization solution that utilizes computer vision and other sensor-based data analysis. The acquisition would help Dynamics Connected Store of Microsoft to better evaluate personalized store spaces. May-2021: Epicor completed the acquisition of KBMax, a configure-price-quote (CPQ) company. Through this acquisition, Epicor aimed to boost its consistent growth further with the capability to provide KBMax software as a stand-alone cloud-first, low/no-code toolset, or integrated into the Epicor productivity portfolio to develop new, cross-and-up sell potential. Mar-2021: Sage completed the acquisition of Task Sheriff, an AI-based SaaS technology start-up based in Tel Aviv, Israel. The acquisition aimed to bolster Sage’s customer experience as emerging and advanced technologies continue to drive real business benefits. Aug-2020: Aptean acquired Innovative Systems, a leading vendor of enterprise resource planning (ERP) software solutions, and electronic data interchange (EDI) mapping and transaction support services. Through this acquisition, Innovative Systems would facilitate Aptean to build its presence in the apparel and distribution segments with customized software solutions for companies of all sizes. Product Launches and Product Expansions: Nov-2021: QAD introduced upgradation in its QAD Adaptive ERP and the QAD Adaptive Applications offerings developed to assist makers to become Adaptive Manufacturing Enterprises. The latest solutions would assist the company’s customers to communicate efficiently and transparently with their suppliers, automating and streaming supplier performance and risk information across the supplier lifecycle. Jul-2021: Infor unveiled FHIR Server, which is designed to assist healthcare firms to better leverage and analyse their data. Infor FHIR Server is based on advanced web technologies and is one of the most sophisticated, latest, and scalable FHIR servers commercially available. With the help of the FHIR Server, companies become capable of expanding their electronic health records and clinical systems’ Fast Healthcare Interoperability Resource (FHIR) and application programming interface (API) capabilities beyond their existing limited support, simplify care coordination by offering required information to vendors as well as patients, and accelerate their organization’s digital transformation while using current clinical systems linked to an advanced FHIR-based ecosystem. Business Expansions: Jul-2021: Sage rolled out TilliT SaaS and IoT service as a separate business. The newly expanded TilliT platform is capable to operate standalone between the ERP and the machine control layer to digitalize the operation or co-exist with present tools in place because to its flexibility and simple installation as a cloud solution. Scope of the Study Market Segments covered in the Report: By Function • Finance and Billing • Supply Chain and Logistics Management • Inventory and Material Management • Patient Relationship Management • Others By Deployment • On-premises • Cloud By Geography • North America o US o Canada o Mexico o Rest of North America • Europe o Germany o UK o France o Russia o Spain o Italy o Rest of Europe • Asia Pacific o China o Japan o India o South Korea o Singapore o Malaysia o Rest of Asia Pacific • LAMEA o Brazil o Argentina o UAE o Saudi Arabia o South Africa o Nigeria o Rest of LAMEA Companies Profiled • Microsoft Corporation • Oracle Corporation • SAP SE • McKesson Corporation • Sage Group plc • Infor, Inc. (Koch Industries) • Odoo • QAD, Inc. (Thoma Bravo) • Aptean (Vista Equity Partners) • Epicor Software Corporation Unique Offerings • Exhaustive coverage • Highest number of market tables and figures • Subscription based model available • Guaranteed best price • Assured post sales research support with 10% customization free Read the full report: https://www.reportlinker.com/p06193312/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________
Every investor in NIO Inc. ( NYSE:NIO ) should be aware of the most powerful shareholder groups. Generally speaking, as...
Web 3.0 is widely considered to be the next frontier of internet technology, making the metaverse a golden macrotrend for retail investors. The metaverse refers to an easily scalable real-time virtual reality or mixed reality world, comprising several interoperable, immersive, and interactive 3D environments. The metaverse is also expected to maintain all relevant information about payments, identity, and history across user sessions.
As we get ready to turn the page on 2021, I can't help but note how we've witnessed a pretty substantial market bifurcation in stocks over the past couple of quarters. Below are four stocks that I believe are likely to find their way into my portfolio in 2022. A year ago, I was completely against electric vehicle (EV) manufacturer Nio (NYSE: NIO).
Since the Great Recession officially ended in 2009, growth stocks have been the driving force on Wall Street. Low lending rates, massive government spending, and the Federal Reserve providing an abundant pool of cheap capital have incentivized businesses to hire, innovate, and acquire other companies. The chickens are now coming home to roost in terms of runaway inflation, and though the Fed has indicated rate hikes are coming to combat high prices, effects won't be felt right away.
It's been a dreadful year for Citigroup (NYSE: C) in terms of stock price performance, with shares of the megabank down about 1% this year. The KBW Nasdaq Bank Index, which tracks large bank stocks, is up nearly 35% this year, showing just how much Citigroup has lagged the broader sector. Trading at beaten-down levels, can Citigroup turn it around in 2022?
ClearBridge Investments, an investment management firm, published its “Small Cap Value Strategy” third quarter 2021 investor letter – a copy of which can be downloaded here. The ClearBridge Small Cap Value Strategy outperformed the Russell 2000 Value Index, the Strategy’s benchmark, during the third quarter of 2021. You can take a look at the fund’s […]
It's hard to find fault with Apple (NASDAQ: AAPL) stock these days. Apple stock is up more than 1,000% over the last decade and has gained nearly 400% over the last three years. Keep reading to see whether you're an Apple bull or bear.
The dividends for such stocks are pretty much their only attraction. On the other hand, you can find dividend stocks that are anything but boring and stodgy. Here are three dividend stocks that soared more than 50% in 2021 and are still great buys.
Abbott Laboratories (NYSE: ABT) shares have gained around 26% in 2021. Despite the big payout bumps, Abbott only needed around 33% of the free cash flow its operations generated over the past year to make dividend payments. Despite pandemic pressure, medical-device segment sales during the first nine months of 2021 rose 24.5% year over year to $10.6 billion.
When looking for the best artificial intelligence stocks to buy, identify companies using AI technology to improve products or gain a strategic edge, such as Google, Microsoft and Nvidia.
This mix of industrial and renewable energy companies could be a great way to generate passive income next year.
Investors in Nio (NYSE: NIO) have been on a roller-coaster ride in 2021, but most of that ride has been downhill. As of the close of trading on Friday, shares of the Chinese electric vehicle (EV) company were down by around 54% from its highest-ever trading price of $66.99 in early January and off by more than 37% year to date. Among other issues, investors are concerned about the rapidly spreading omicron COVID-19 variant and its possible impact on the global economy, ongoing semiconductor chip shortages, increasing U.S. regulatory scrutiny on foreign companies, and fears that a debt default by massive Chinese property developer Evergrande Group might set off a financial crisis in Nio's home market.
Shares of Microbot Medical Inc. rocketed 67.3% toward a nine-month high on heavy volume in premarket trading Monday, after the pre-clinical medical device company announced an agreement with Stryker Corp. to develop the first dedicated robotic procedural kits for use in certain neurovascular procedures. Trading volume ballooned to 9.6 million shares, compared with the full-day average of about 49,000 shares. The stock was the biggest gainer and most actively traded ahead of the open. As part of
Genetic testing company Invitae (NYSE: NVTA) has seen its shares tumble from their highs despite aggressively ramping up its test volumes this year. Investors could buy the dip on Invitae, but they shouldn't ignore a major hang-up on its business model. Invitae generates revenue by administering genetic tests while steadily also building a genome information database over time.
If you have $100 at the ready not needed for bills or emergencies and a brokerage that allows fractional share purchases, you have enough to buy into the following pair of no-brainer stocks right now. Palantir Technologies (NYSE: PLTR) is the Liam Neeson of data analytics stocks: It has a very particular set of skills that were acquired over a very long career. The U.S. military is also a prime customer, using Palantir's technology to coordinate millions of troops around the world.
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
Stocks rose ahead of the traditional Santa Claus rally. Tesla is still rising. AMD leads stocks flashing buy signals.
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...
Naren Gupta, a venture capitalist who co-founded Nexus Venture Partners to help plant Indian SaaS startups on the world map, died on Saturday. Gupta, who moved to the U.S. to pursue higher education in late 1960s, co-founded Integrated Systems, a software firm that was ultimately sold to Intel. After leaving the firm, he began to explore investment opportunities.
There's no denying that 2021 has been a rough year for many biotech stocks. The shares of quite a few big and small biotech companies alike are set to finish the year in negative territory. Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Novartis (NYSE: NVS), and Vertex Pharmaceuticals (NASDAQ: VRTX).